Use of health care services by patients with psoriasis: A population-based study

British Journal of Dermatology

Volumn 172, Issue 5, 2015, Pages 1346-1352

  Kao, L T ^a,b   Wang, K H ^b   Lin, H C ^b   Li, H C ^b   Yang, S ^c   Chung, S D ^b,d,e  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^e FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMBULATORY CARE; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FAMILY MEDICINE; FEMALE; GYNECOLOGY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; INCOME; INTERNAL MEDICINE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSTETRICS; OUTPATIENT CARE; POPULATION RESEARCH; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; TAIWAN; URBANIZATION; VERY ELDERLY; YOUNG ADULT; ADOLESCENT; ECONOMICS; HEALTH SERVICE; HOSPITALIZATION; PATIENT ATTITUDE; STATISTICS AND NUMERICAL DATA; UTILIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PSORIASIS; TAIWAN; YOUNG ADULT;

EID: 84929133398     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13442     Document Type: Article

References (35)

1. Raychaudhuri SK, Maverakis E, Raychaudhuri SP,. Diagnosis and classification of psoriasis. Autoimmun Rev 2014; 13: 490-5.
2. Chandran V, Raychaudhuri SP,. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 2010; 34: J314-21.
3. Stern RS, Nijsten T, Feldman SR, et al,. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004; 9: 136-9.
4. Horn EJ, Fox KM, Patel V, et al,. Association of patient-reported psoriasis severity with income and employment. J Am Acad Dermatol 2007; 57: 963-71.
5. Gelfand JM, Feldman SR, Stern RS, et al,. Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol 2004; 51: 704-8.
6. Galadari I, Rigel E, Lebwohl M,. The cost of psoriasis treatment. J Eur Acad Dermatol Venereol 2001; 15: 290-1.
7. Beyer V, Wolverton SE,. Recent trends in systemic psoriasis treatment costs. Arch Dermatol 2010; 146: 46-54.
8. Yu AP, Tang J, Xie J, et al,. Economic burden of psoriasis compared to the general population and stratified by disease severity. Curr Med Res Opin 2009; 25: 2429-38.
9. Navarini AA, Laffitte E, Conrad C, et al,. Estimation of cost-of-illness in patients with psoriasis in Switzerland. Swiss Med Wkly 2010; 140: 85-91.
10. Clombo G, Altomare G, Peris K, et al,. Moderate and severe plaque psoriasis: cost-of-illness study in Italy. Ther Clin Risk Manag 2008; 4: 559-68.
11. Schoffski O, Augustin M, Prinz J, et al,. Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multi-center study. J Dtsch Dermatol Ges 2007; 5: 209-18.
12. Carrascosa JM, Pujol R, Dauden E, et al,. A prospective evaluation of the cost of psoriasis in Spain (EPIDERMA project: phase II). J Eur Acad Dermatol Venereol 2006; 20: 840-5.
13. Berger K, Ehlken B, Kugland B, et al,. Cost-of-illness in patients with moderate and severe chronic psoriasis vulgaris in Germany. J Dtsch Dermatol Ges 2005; 3: 511-18.
14. Feldman SR, Fleischer AB Jr, Reboussin DM, et al,. The economic impact of psoriasis increases with psoriasis severity. J Am Acad Dermatol 1997; 37: 564-9.
15. Javitz HS, Ward MM, Farber E, et al,. The direct cost of care for psoriasis and psoriatic arthritis in the United States. J Am Acad Dermatol 2002; 46: 850-60.
16. Levy AR, Davie AM, Brazier NC, et al,. Economic burden of moderate to severe plaque psoriasis in Canada. Int J Dermatol 2012; 51: 1432-40.
17. Chen YC, Yeh HY, Wu JC, et al,. Taiwan's National Health Insurance Research Database: administrative health care database as study object in bibliometrics. Scientometrics 2011; 86: 365-80.
18. Liu T-C, Chen C-S,. An analysis of private health insurance purchasing decisions with national health insurance in Taiwan. Soc Sci Med 2002; 55: 755-74.
19. von Elm E, Altman DG, Egger M, et al,. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61: 344-9.
20. Gottlieb AB, Dann F,. Comorbidities in patients with psoriasis. Am J Med 2009; 122: 1150 e1-9.
21. Gottlieb AB, Chao C, Dann F,. Psoriasis comorbidities. J Dermatolog Treat 2008; 19: 5-21.
22. Prodanovich S, Kirsner RS, Kravetz JD, et al,. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol 2009; 145: 700-3.
23. Christophers E,. Comorbidities in psoriasis. Clin Dermatol 2007; 25: 529-34.
24. Armstrong AW, Schupp C, Bebo B,. Psoriasis comorbidities: results from the National Psoriasis Foundation surveys 2003 to 2011. Dermatology 2012; 225: 121-6.
25. Augustin M, Reich K, Glaeske G, et al,. Co-morbidity and age-related prevalence of psoriasis: analysis of health insurance data in Germany. Acta Derm Venereol 2010; 90: 147-51.
26. Crown WH, Bresnahan BW, Orsini LS, et al,. The burden of illness associated with psoriasis: cost of treatment with systemic therapy and phototherapy in the US. Curr Med Res Opin 2004; 20: 1929-36.
27. Kimball AB, Guerin A, Tsaneva M, et al,. Economic burden of comorbidities in patients with psoriasis is substantial. J Eur Acad Dermatol Venereol 2011; 25: 157-63.
28. Yeung H, Takeshita J, Mehta NN, et al,. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol 2013; 149: 1173-9.
29. Langley RGB, Krueger GG, Griffiths CEM,. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005; 64: ii18-23.
30. Wu T-Y, Majeed A, Kuo KN,. An overview of the healthcare system in Taiwan. Lond J Prim Care 2010; 3: 115-19.
31. Lee S-Y, Chun C-B, Lee Y-G, et al,. The National Health Insurance system as one type of new typology: the case of South Korea and Taiwan. Health Policy 2008; 85: 105-13.
32. Chen GJ, Feldman SR,. Economic aspect of health care systems: advantage and disadvantage incentives in different systems. Dermatol Clin 2000; 18: 211-14.
33. Chang YT, Chen TJ, Liu PC, et al,. Epidemiological study of psoriasis in the national health insurance database in Taiwan. Acta Derm Venereol 2009; 89: 262-6.
34. Chen Y-J, Wu C-Y, Chen T-J, et al,. The risk of cancer in patients with psoriasis: a population-based cohort study in Taiwan. J Am Acad Dermatol 2011; 65: 84-91.
35. Tsai T-F, Wang T-S, Hung S-T, et al,. Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan. J Dermatol Sci 2011; 63: 40-6.